Blackstone Labs | BSL ABNORMAL | 60 Tablets

Blackstone Labs ABNORMAL is not a general muscle builder, test booster, or entry-level performance formula. It is a 19-NorDHEA-based prohormone product built around a nandrolone-precursor concept, and that places it in a completely different category from conventional sports nutrition. The formulation strategy is straightforward: provide a 19-NorDHEA blend totaling 50 mg per tablet using multiple forms of the same core precursor system rather than a wide ingredient panel. According to the verified label, those forms are 19-NorAndrost-4-ene-3b-ol, 17-one, plus decanoate and enanthate esters of that same active. The intended logic is a staggered exposure profile, where the base form contributes more immediate availability while the esterified forms are positioned as slower-release variants.

Mechanistically, 19-NorDHEA compounds are used as precursors in pathways associated with nandrolone-like anabolic activity. In practical terms, this category is used to support increases in training output, muscle accrual, and recovery capacity beyond what non-hormonal ergogenics typically deliver. Users generally do not "feel" this the way they feel a stimulant pre-workout. There is no acute rush. What they usually notice is progressive: improved session-to-session performance, better gym drive, increased fullness, easier maintenance of strength under higher training volume, and a denser look over time. That is the core experience this formula is chasing.

The biggest formulation issue is transparency. The total 19-NorDHEA blend is disclosed at 50 mg, but the individual amounts of the base, decanoate, and enanthate forms are not. In a category this serious, that matters. Proprietary blends are common in legacy prohormone products, but they are still a weakness because the customer cannot verify how much of the blend is immediate versus esterified material, or compare those individual inputs to historical category norms. Some external research context suggests users often take 2 tablets daily for 100 mg total, but the exact per-form distribution remains undisclosed on the verified formula data provided here.

The inclusion of phosphatidylcholine and hydroxypropyl-beta-cyclodextrin in the inactive matrix is notable because both are often used in advanced delivery systems. HPβCD can improve solubilization of lipophilic compounds, and phosphatidylcholine is commonly associated with lipid-based transport concepts. That does not replace transparent active dosing, but it does support the idea that the formula was designed around enhanced handling of a poorly water-soluble hormone precursor.

As a system, ABNORMAL is simple: one hormonal pathway, delivered in multiple forms, in tablet format, with excipients that suggest a solubility/absorption-focused design. What should you expect? Day 1, usually not much acutely beyond the knowledge that you have started a hormonal cycle. Over the first 1-2 weeks, experienced users typically watch for subtle changes in training aggression, workload tolerance, and muscle fullness. By weeks 2-4, the expected use case is more obvious: better leverage on progressive overload, easier recovery between demanding sessions, and a more pronounced lean-mass look if food intake and training are in place. The most important caveat is also the most important truth: this is a hormone-active product with incomplete label transparency, and it should be approached with the seriousness that implies.

How to Use Blackstone Labs - ABNORMAL (ProHormone)